Explore 3 Stock Ideas & Industry Insights Download Free Report

General News

Did You Catch the Big Tech Earnings Reactions? Microsoft (NASDAQ:MSFT), Meta (NASDAQ:META), Netflix (NASDAQ:NFLX) and More

Reactions have split on what spending buys. Microsoft (NASDAQ:MSFT) fell about 5% on April 30 after a $190 billion capex plan and closed at $532.95 on October 21, while Meta (NASDAQ:META) reported third-quarter free cash flow of negative $2.12 billion. Alphabet (NASDAQ:GOOGL) rose about …

Vinay Lochav | 23 October 2026

What Should Investors Watch in Amazon, Microsoft, Alphabet and Intel Earnings Next Week After Meta's Report?

Four of the market's most closely watched AI spenders report over two days. Microsoft (NASDAQ:MSFT) and Alphabet (NASDAQ:GOOGL) release results after the close on Wednesday, October 28, with Microsoft's call at 2:30 p.m. Pacific and Alphabet's at 4:30 p.m. Eastern.

Vinay Lochav | 23 October 2026

Big Tech Earnings Week Wrap: Who Beat, Who Missed and Who Was Punished Anyway Before Microsoft Reports October 28?

The week's reporters beat on profit and still met mixed reactions. Netflix (NASDAQ:NFLX) reported on Tuesday, October 20, with earnings of $0.87 per share against $0.82 expected, but shares fell 5.31% to $65.04 on October 21 as its 2026 advertising forecast was cut to …

Vinay Lochav | 23 October 2026

Which Biotech Catalysts Mattered This Week? FDA Clinical Hold Lifts, CAR-T Pivots, Medicare Reimbursement and More

What Are the Biggest Biotech Catalysts This Week, From Kidney Week Data to FDA Holds and Medicare Rates?

Vinay Lochav | 23 October 2026

Why Are Biotech Stocks Swinging on No News, and Is It a Pattern or a Red Flag That Investors May Be Missing?

It appears to be a recurring pattern in small and mid-sized biotech, and the absence of a headline is not by itself a warning. Shares of companies with no sales are priced on expectations for trials and regulators, so they can move when holders …

Vinay Lochav | 23 October 2026

Why Is Biotech Catalyst Week Moving Stocks, and What Do Kidney Week Data and FDA Holds Reveal That Investors May Miss?

Biotech shares are reacting this week to a rare stacking of catalysts: a large medical meeting, a regulatory reversal and a filing decision, all inside a few trading days. The American Society of Nephrology's Kidney Week runs from October 21 to 25 in Denver …

Vinay Lochav | 23 October 2026

Bitcoin Price: Why Is Bitcoin Still About 35% Below Its 2025 Peak and Hovering Near $80,000?

Bitcoin was trading near $81,500 on Friday, October 23, which is roughly 35.4% below the record of about $126,200 set on October 6, 2025. The gap reflects a year in which the largest cryptocurrency spent much of 2026 in a bear market, then staged …

Vinay Lochav | 23 October 2026

Bitcoin ETF Flows This Week: Why Did a $635.6 Million Outflow Follow Two Large Inflow Days?

US spot bitcoin ETFs recorded net outflows of $635.6 million on Thursday, October 22, the day bitcoin dipped below $80,000 for the first time in about a month. It was the largest daily withdrawal since the $484.9 million recorded on October 7, and it …

Vinay Lochav | 23 October 2026

Booz Allen Hamilton (NYSE:BAH) Earnings: What Are Investors Watching in the Second-Quarter Report After a 16% Civil Revenue Drop?

Booz Allen Hamilton (NYSE:BAH) reports fiscal second-quarter 2027 results on Friday, October 23, with a call at 8:00 a.m. Eastern time. The focus is whether revenue can stabilize after the first quarter, when it fell 4.2% to $2.80 billion even as adjusted EPS rose …

Vinay Lochav | 23 October 2026

Why Are Buyback Announcements Piling Up After Earnings, and Which Companies Are Pulling Back?

Several companies paired third-quarter results with new repurchase authorizations this week, though not every program is new. General Motors (NYSE:GM) announced a multi-year $20 billion authorization with no expiration date on Tuesday, October 20. It follows a separate $6 billion program announced in January.

Vinay Lochav | 23 October 2026
Support

Hi! How can we help you today?

Loading…